{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"2.290","rs_stock_flag":false,"fiscal_year_end":"31 Dec 2024","hist_closedate":"25 Sep 2025","replication_method":null,"amt_os":"772,787,887","primaryexch":"HKEX","ric":"1875.HK","product_subtype":null,"db_updatetime":"26 Sep 2025 18:38","mkt_cap_u":"B","am_u":"K","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0479,"inline_upper_strike_price":"","sedol":"BKKLNR0","am":"186.74","iv":"","ew_strike":"","as":"2.290","geographic_focus":null,"incorpin":"Hong Kong","etp_baseCur":null,"ew_amt_os":"","bd":"2.220","registrar":"Tricor Investor Services Ltd.","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"400","update_time":"2025-09-26 10:38:37.0","lo52":"1.480","shares_issued_date":"31 Aug 2025","premium":"","strike_price_ccy":null,"yield":"","vo_u":"K","base_currency":null,"coupon":"","expiry_date":"","chairman":"Fu Shan","underlying_ric":"1875.HK","hi52":"2.940","issuer_name":"BioDlink International Co. Ltd. - B","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"26 Sep 2025 16:08","aum_date":"","lo":"2.220","mkt_cap":"1.76","f_aum_hkd":null,"ew_sub_per_to":"","ls":"2.290","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"Healthcare - Pharmaceuticals & Biotechnology","ew_desc":null,"inception_date":"","nc":"+0.030","aum":"","issued_shares_class_B":null,"vo":"82.80","secondary_listing_flag":false,"listing_date":"8 Nov 2019","issued_shares_class_A":null,"as_at_label":"as at","ew_amt_os_dat":"","nm":"BioDlink International Co. Ltd. - B","nm_s":"BIODLINK-B","sym":"1875","inline_lower_strike_price":"","listing_category":"Primary Listing","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"BioDlink International Co Ltd, formerly TOT BIOPHARM International Co Ltd, is a clinical-stage biopharmaceutical company principally engaged in developing and commercializing oncology drugs and therapies. The Company and its subsidiaries are primarily engaged in research, development, manufacturing, and marketing of anti-tumor drugs, contract development and manufacturing organization (CDMO) business and license-out of self-developed biological drugs in the Peopleâ€™s Republic of China. The Company owns a pipeline of oncology drug candidates, which include monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs). The Company has built and established a fully integrated in-house platform of discovery, process development, quality management, pre-clinical and clinical development, as well as commercial-scale manufacturing facilities and sales and marketing capabilities. The Company mainly conducts its businesses in the domestic market.","op":"2.280","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"Biotechnology","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"Room 1918, 19/F<br/>Lee Garden One<br/>33 Hysan Avenue<br/>Causeway Bay, Hong Kong","pc":"+1.33","days_to_expiry":null,"underlying_code":null,"pe":"45.26","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"2.260","isin":"HK0000545266","moneyness":""}},"qid":"1758890888377"}
